Tryptase expression as a prognostic marker in patients with resected gastric cancer.
Published: 24th May 2017
Authors: C. Lin, H. Liu, H. Zhang, Y. Cao, R. Li, S. Wu et al.
Mast cells play important roles in the progression of various malignancies, but their prognostic value in gastric cancer is unknown. Tryptase expression, as an indicator of mast cell activity, was therefore evaluated to see whether this could be incorporated usefully into a prognostic nomogram after surgery in patients with gastric cancer.
Tissue microarrays from patients with gastric cancer were created from formalin‐fixed, paraffin‐embedded resection specimens. Tryptase density was assessed by immunohistochemistry, and the association between tryptase expression and prognosis was evaluated. Semiquantitative scoring was devised to determine an optimal cut‐off value that correlated with survival. A prognostic nomogram was then developed incorporating tryptase expression scores along with other variables known to be related to survival.
Tissue microarrays were generated from 419 patients having surgery for gastric cancer. Increased tryptase expression was associated with better overall and recurrence‐free survival (both
Tryptase expression is an independent prognostic factor for overall and recurrence‐free survival in patients with gastric cancer after surgical resection.Read more
You may also be interested in
[18F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Authors: T. Harustiak, M. Zemanova, P. Fencl, L. Hornofova, A. Pazdro, M. Snajdauf et al.
Notes: Of no use
Meta‐analysis of delayed gastric emptying after pylorus‐preserving versus pylorus‐resecting pancreatoduodenectomy.
Authors: U. Klaiber, P. Probst, O. Strobel, C. W. Michalski, C. Dörr‐Harim, M. K. Diener et al.
Notes: No difference
Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer.
Authors: J. A. H. Gooszen, L. Goense, S. S. Gisbertz, J. P. Ruurda, R. van Hillegersberg, M. I. van Berge Henegouwen et al.
Notes: Chest lower leak rates
Meta‐analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus. BJS 2018; 105: 168-181.
Authors: A. T. Billeter, K. M. Scheurlen, P. Probst, S. Eichel, F. Nickel, S. Kopf et al.
Notes: Surgery is better
Health‐related quality of life after open transhiatal and transthoracic oesophagectomy for cancer. BJS 2018; 105: 230-236.
Authors: J. H. Kauppila, A. Johar, J. A. Gossage, A. R. Davies, J. Zylstra, J. Lagergren et al.
Notes: Favours transhiatal
Patient‐derived organoid models help define personalized management of gastrointestinal cancer. BJS 2018; 105: e48-e60.
Authors: M. R. Aberle, R. A. Burkhart, H. Tiriac, S. W. M. Olde Damink, C. H. C. Dejong, D. A. Tuveson et al.
Notes: Accelerating the science of personal care
Meta‐analysis of the prognostic value of CpG island methylator phenotype in gastric cancer. BJS 2018; 105: e61-e68.
Authors: A. G. M. T. Powell, S. Soul, A. Christian, W. G. Lewis
Notes: Heterogeneity in gene panels used
Authors: K. Boye, J.‐M. Berner, I. Hompland, Ø. S. Bruland, S. Stoldt, K. Sundby Hall et al.
Notes: Handle with care
Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. BJS 2018; 105: e176-e182.
Authors: R. T. van der Kaaij, J. P. van Kessel, J. M. van Dieren, P. Snaebjornsson, O. Balagué, F. van Coevorden et al.
Notes: Frozen section of margins is key
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer. BJS 2018; 105: e110-e120.
Authors: O. Nordgård, K. Tjensvoll, B. Gilje, K. Søreide
Notes: The inner space frontier
Comparison of gaze behaviour of trainee and experienced surgeons during laparoscopic gastric bypass. BJS 2018; 105: 287-294.
Authors: S. Erridge, H. Ashraf, S. Purkayastha, A. Darzi, M. H. Sodergren
Notes: Potential uses in training and assessment
Impact of weight loss and eating difficulties on health‐related quality of life up to 10 years after oesophagectomy for cancer.
Authors: P. Anandavadivelan, A. Wikman, A. Johar, P. Lagergren
Notes: Associated with deterioration of HRQOL